1. Home
  2. NPV vs SLN Comparison

NPV vs SLN Comparison

Compare NPV & SLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nuveen Virginia Quality Municipal Income Fund

NPV

Nuveen Virginia Quality Municipal Income Fund

HOLD

Current Price

$11.73

Market Cap

207.1M

Sector

Finance

ML Signal

HOLD

Logo Silence Therapeutics Plc American Depository Share

SLN

Silence Therapeutics Plc American Depository Share

HOLD

Current Price

$5.03

Market Cap

236.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NPV
SLN
Founded
1993
1994
Country
United States
United Kingdom
Employees
N/A
116
Industry
Investment Managers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
207.1M
236.2M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
NPV
SLN
Price
$11.73
$5.03
Analyst Decision
Buy
Analyst Count
0
6
Target Price
N/A
$39.67
AVG Volume (30 Days)
38.0K
185.7K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
3.90%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$10.68
$1.97
52 Week High
$12.50
$7.78

Technical Indicators

Market Signals
Indicator
NPV
SLN
Relative Strength Index (RSI) 67.35 48.57
Support Level $11.36 $5.17
Resistance Level N/A $6.10
Average True Range (ATR) 0.09 0.53
MACD 0.00 0.10
Stochastic Oscillator 70.42 37.88

Price Performance

Historical Comparison
NPV
SLN

About NPV Nuveen Virginia Quality Municipal Income Fund

Nuveen Virginia Quality Municipal Income Fund is a diversified closed-end management investment company. The fund seeks to provide current income exempt from both regular federal and designated state income taxes. The fund invests in a portfolio of municipal obligations issued by state and local government authorities. Company mostly invest in Education and Civic Organizations, Tax Obligation/General, Healthcare, Utilities , Housing/Multifamily, Transportation, and Others.

About SLN Silence Therapeutics Plc American Depository Share

Silence Therapeutics PLC is a biotechnology company focused on discovering and developing novel molecules incorporating short-interfering ribonucleic acid or siRNA. Using its mRNAi GOLD platform, the company has generated siRNA product candidates both for internal development pipeline as well as for out-licensed programs with third-party collaborators. Its wholly owned pipeline is focused on three therapeutic areas: cardiovascular disease, hematology, and rare diseases. The different product candidates in its pipeline are Divesiran (SLN124), a siRNA product candidate that has the potential to treat several hematological disorders; Zerlasiran (SLN360), being developed as a potential treatment to reduce cardiovascular issues; SLN-312; SLN-548; and multiple other programs.

Share on Social Networks: